George Kegler
Direktor/Vorstandsmitglied bei ENVERIC BIOSCIENCES, INC.
Vermögen: 288 $ am 30.04.2024
Profil
George A.
Kegler is currently the Director at Jay Pharma, Inc. (Canada) and an Independent Director at Enveric Biosciences, Inc. He was previously the President-Specialty Generics Business at Mallinckrodt Plc, Chief Financial Officer & Executive VP at Mallinckrodt Plc, and Chief Financial Officer at ConvaTec, Inc. Kegler received his undergraduate degree from the University of Missouri and his MBA from St. Louis University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
08.04.2024 | 320 ( 0,00% ) | 288 $ | 30.04.2024 |
Aktive Positionen von George Kegler
Unternehmen | Position | Beginn |
---|---|---|
ENVERIC BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 30.12.2020 |
Jay Pharma, Inc. (Canada)
Jay Pharma, Inc. (Canada) Pharmaceuticals: OtherHealth Technology Jay Pharma, Inc. engages in development of evidence-based products and combination therapies to address unmet needs in cancer care. It offers safe cannabinoid products for persons suffering from the side effects of cancer. The company was founded on April 19, 2017 and is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | 31.12.2020 |
Ehemalige bekannte Positionen von George Kegler
Unternehmen | Position | Ende |
---|---|---|
MALLINCKRODT PLC | Finanzdirektor/CFO | 18.03.2019 |
ConvaTec, Inc.
ConvaTec, Inc. Medical SpecialtiesHealth Technology ConvaTec, Inc. engages in the manufacture of medical products and technologies focused on therapies for the management of chronic conditions. It specializes in the wound care, ostomy care, continence and critical care, and infusion devices. The company was founded in 1978 and is headquartered in Bridgewater, NJ. | Finanzdirektor/CFO | 26.04.2012 |
MALLINCKRODT PLC | Corporate Officer/Principal | - |
Ausbildung von George Kegler
University of Missouri | Undergraduate Degree |
St. Louis University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
MALLINCKRODT PLC | Health Technology |
ENVERIC BIOSCIENCES, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
ConvaTec, Inc.
ConvaTec, Inc. Medical SpecialtiesHealth Technology ConvaTec, Inc. engages in the manufacture of medical products and technologies focused on therapies for the management of chronic conditions. It specializes in the wound care, ostomy care, continence and critical care, and infusion devices. The company was founded in 1978 and is headquartered in Bridgewater, NJ. | Health Technology |
Jay Pharma, Inc. (Canada)
Jay Pharma, Inc. (Canada) Pharmaceuticals: OtherHealth Technology Jay Pharma, Inc. engages in development of evidence-based products and combination therapies to address unmet needs in cancer care. It offers safe cannabinoid products for persons suffering from the side effects of cancer. The company was founded on April 19, 2017 and is headquartered in Toronto, Canada. | Health Technology |